| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.6 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |